Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants

Author(s):  
Monica Losi ◽  
Paola Dal Monte ◽  
Roberto Cagarelli ◽  
Marisa Meacci ◽  
Cinzia Del Giovane ◽  
...  
2020 ◽  
Vol 99 (6) ◽  
pp. 231-235
Author(s):  
O.E. Russkikh ◽  
◽  
D.A. Kudlay ◽  
◽  

The review presents scientific data available to date on the concept of the emergence and spread of latent tuberculosis infection (TI) in the current tuberculosis epidemic situation in society. Information on modern immunological tests for TI diagnosis is presented and the significant role of IGRA tests in the diagnostic tactics of detecting latent TI in various population groups is determined.


2012 ◽  
Vol 63 (1) ◽  
pp. 49-59 ◽  
Author(s):  
Anamarija Jurčev-Savičević ◽  
Vera Katalinić-Janković ◽  
Kornelija Miše ◽  
Ivan Gudelj

The Role of Interferon-gamma Release Assay in Tuberculosis ControlTuberculosis is still one of the major global public health threats. Countries with low incidence must focus on exhausting the reservoir of future cases by preventing reactivation. Therefore, it is important to identify and effectively treat those individuals who have latent tuberculosis infection and who may develop active disease. The tuberculin skin test has been the standard for detection of immune response against M. tuberculosis since the beginning of the 20th century. The new millennium has brought advancement in the diagnosis of latent tuberculosis infection. The name of the new blood test is interferon-gamma release assay (IGRA). Croatia is a middle-incidence country with a long decreasing trend and developed tuberculosis control. To reach low incidence and finally eliminate tuberculosis, its tuberculosis programme needs a more aggressive approach that would include intensive contact investigation and treatment of persons with latent tuberculosis infection. This article discusses the current uses of IGRA and its role in tuberculosis control.


2014 ◽  
Vol 8 (12) ◽  
pp. 1310-1317
Author(s):  
Abdel Aziz Amer Safaa ◽  
Mahmoud El Hefnawy Azza ◽  
Abdel Hameed Harfoush Reem ◽  
Samy Saad Mona

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Arpana Verma ◽  
Maninder Kaur ◽  
Lakshya Veer Singh ◽  
Divya Aggarwal ◽  
Indu Verma ◽  
...  

AbstractThe evidence of an association between diabetes and latent tuberculosis infection (LTBI) remains limited and inconsistent. Thus, the study aims to delineate the role of diabetes in activation of latent tuberculosis infection. Murine model of latent tuberculosis and diabetes was developed, bacillary load and gene expression of resuscitation promoting factors (rpfA-E) along with histopathological changes in the lungs and spleen were studied. Treatment for LTBI [Rifampicin (RIF) + Isoniazid (INH)] was also given to latently infected mice with or without diabetes for 4 weeks. Diabetes was found to activate latent tuberculosis as the colony forming unit (CFU) counts were observed to be > 104 in lungs and spleen. The gene expression of hspX was downregulated and that of rpfB and rpfD was observed to be upregulated in latently infected mice with diabetes compared to those without diabetes. However, no significant reduction in the CFU counts was observed after 4 weeks of treatment with RIF and INH. Diabetes helps in the progression of LTBI to active disease mainly through altered expression of resuscitation promoting factors rpfB and rpfD, which can serve as important targets to reduce the shared burden of tuberculosis and diabetes.


Sign in / Sign up

Export Citation Format

Share Document